Page last updated: 2024-10-31

neostigmine and Dyskinesia, Medication-Induced

neostigmine has been researched along with Dyskinesia, Medication-Induced in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
"Deanol was not found to be effective in this group of patients; the authors suggest that this drug should not be assumed to be generally effective unless effectiveness is verified by a large placebo-controlled double-blind study."2.64Cholinergic influences in tardive dyskinesia. ( Chang, S; Davis, JM; Ericksen, SE; Smith, RC; Tamminga, CA, 1977)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamminga, CA1
Smith, RC1
Ericksen, SE1
Chang, S1
Davis, JM1

Trials

1 trial available for neostigmine and Dyskinesia, Medication-Induced

ArticleYear
Cholinergic influences in tardive dyskinesia.
    The American journal of psychiatry, 1977, Volume: 134, Issue:7

    Topics: Acetylcholine; Administration, Oral; Basal Ganglia; Choline; Deanol; Dyskinesia, Drug-Induced; Ethan

1977